ArticleDrug metabolism and disposition: the biological fate of chemicals2025

Characterization of genetically modified human embryonic kidney 293 cells lacking equilibrative nucleoside transporter subtype 2, or both subtypes 1 and 2, and the impact of their loss on sensitivity to chemotherapeutic purine/pyrimidine analogs.

Nayiar Shahid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.